PBA (Ammonaps) in the prevention of intraocular pressure rise caused by corticosteroid eye drops
- Conditions
- Intraocular pressure increase caused by glucocorticoid use in genetically predisposed patientsTherapeutic area: Diseases [C] - Eye Diseases [C11]
- Registration Number
- EUCTR2015-000225-36-FI
- Lead Sponsor
- Helsinki University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Patients with glucocorticoid caused raise in intraocular pressure encountered in clinical work at Helsinki University Hospital Uveitis dpt
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 30
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Age (<18 or >65 years), gravid and nursing mothers
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method